<h3>漲幅股</h3>
<ul>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 的股票在週五的盤前交易中上漲了 40.4%，至$0.55。其流通股的市值為 130 萬美元。</li>
<li><strong>Cardio Diagnostics Hldgs</strong> (NASDAQ: CDIO) 的股票上漲了 23.18%，至$6.43。其流通股的市值為 950 萬美元。</li>
<li><strong>Neurogene</strong> (NASDAQ: NGNE) 的股票上漲了 20.93%，至$23.8。公司的市值為 3.048 億美元。</li>
<li><strong>Caris Life Sciences</strong> (NASDAQ: CAI) 的股票上漲了 14.81%，至$22.09。其流通股的市值為 54 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
<li><strong>BioAtla</strong> (NASDAQ: BCAB) 的股票上漲了 10.78%，至$0.26。其流通股的市值為 1760 萬美元。</li>
<li><strong>Candel Therapeutics</strong> (NASDAQ: CADL) 的股票上漲了 8.73%，至$5.6。公司的市值為 2.827 億美元。</li>
</ul>
<h3>跌幅股</h3>
<ul>
<li><strong>Emergent BioSolutions</strong> (NYSE: EBS) 的股票在週五的盤前交易中下跌了 21.8%，至$8.68。公司的市值為 5.829 億美元。根據新聞，第四季度的財報昨天發佈。</li>
<li><strong>XORTX Therapeutics</strong> (NASDAQ: XRTX) 的股票下跌了 17.58%，至$0.33。其流通股的市值為 280 萬美元。</li>
<li><strong>Ginkgo Bioworks Holdings</strong> (NYSE: DNA) 的股票下跌了 16.69%，至$8.09。其流通股的市值為 5.883 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
<li><strong>Fortrea Holdings</strong> (NASDAQ: FTRE) 的股票下跌了 13.43%，至$9.35。其流通股的市值為 9.979 億美元。根據新聞，第四季度的財報昨天發佈。</li>
<li><strong>Amphastar Pharma</strong> (NASDAQ: AMPH) 的股票下跌了 13.18%，至$23.0。公司的市值為 12 億美元。公司的第四季度財報昨天發佈。</li>
<li><strong>Seer</strong> (NASDAQ: SEER) 的股票下跌了 12.99%，至$1.81。公司的市值為 1.17 億美元。根據新聞稿，第四季度的財報昨天發佈。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>

標普全球醫療股指數 ETF - iShares

醫藥突破 ETF - ALPS

納斯達克生物科技指數 ETF - iShares Nasdaq

<p>在週五的盤前交易中，幾隻醫療保健股票經歷了顯著波動。Ensysce Biosciences (ENSC) 上漲了 40.4%，至 $0.55，而 Cardio Diagnostics Hldgs (CDIO) 上漲了 23.18%，至 $6.43。Neurogene (NGNE) 增加了 20.93%，至 $23.8，Caris Life Sciences (CAI) 上漲了 14.81%，至 $22.09。相反，Emergent BioSolutions (EBS) 下跌了 21.8%，至 $8.68，XORTX Therapeutics (XRTX) 下跌了 17.58%，至 $0.33。Ginkgo Bioworks (DNA) 下跌了 16.69%，至 $8.09，而 Fortrea Holdings (FTRE) 下跌了 13.43%，至 $9.35。其他顯著的下跌股票包括 Amphastar Pharma (AMPH) 和 Seer (SEER)</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>漲幅股</h3>
</div><ul>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) shares rose 40.4% to $0.55 during Friday's pre-market session. The market value of their outstanding shares is at $1.3 million.</li>
<li><strong>Cardio Diagnostics Hldgs</strong> (NASDAQ: CDIO) stock rose 23.18% to $6.43. The market value of their outstanding shares is at $9.5 million.</li>
<li><strong>Neurogene</strong> (NASDAQ: NGNE) shares rose 20.93% to $23.8. The company's market cap stands at $304.8 million.</li>
<li><strong>Caris Life Sciences</strong> (NASDAQ: CAI) stock increased by 14.81% to $22.09. The market value of their outstanding shares is at $5.4 billion. As per the press release, Q4 earnings came out yesterday.</li>
<li><strong>BioAtla</strong> (NASDAQ: BCAB) shares moved upwards by 10.78% to $0.26. The market value of their outstanding shares is at $17.6 million.</li>
<li><strong>Candel Therapeutics</strong> (NASDAQ: CADL) stock increased by 8.73% to $5.6. The company's market cap stands at $282.7 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 的股票在週五的盤前交易中上漲了 40.4%，至$0.55。其流通股的市值為 130 萬美元。</li>
<li><strong>Cardio Diagnostics Hldgs</strong> (NASDAQ: CDIO) 的股票上漲了 23.18%，至$6.43。其流通股的市值為 950 萬美元。</li>
<li><strong>Neurogene</strong> (NASDAQ: NGNE) 的股票上漲了 20.93%，至$23.8。公司的市值為 3.048 億美元。</li>
<li><strong>Caris Life Sciences</strong> (NASDAQ: CAI) 的股票上漲了 14.81%，至$22.09。其流通股的市值為 54 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
<li><strong>BioAtla</strong> (NASDAQ: BCAB) 的股票上漲了 10.78%，至$0.26。其流通股的市值為 1760 萬美元。</li>
<li><strong>Candel Therapeutics</strong> (NASDAQ: CADL) 的股票上漲了 8.73%，至$5.6。公司的市值為 2.827 億美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅股</h3>
</div><ul>
<li><strong>Emergent BioSolutions</strong> (NYSE: EBS) stock decreased by 21.8% to $8.68 during Friday's pre-market session. The company's market cap stands at $582.9 million. As per the news, the Q4 earnings report came out yesterday.</li>
<li><strong>XORTX Therapeutics</strong> (NASDAQ: XRTX) shares fell 17.58% to $0.33. The market value of their outstanding shares is at $2.8 million.</li>
<li><strong>Ginkgo Bioworks Holdings</strong> (NYSE: DNA) stock declined by 16.69% to $8.09. The market value of their outstanding shares is at $588.3 million. As per the press release, Q4 earnings came out yesterday.</li>
<li><strong>Fortrea Holdings</strong> (NASDAQ: FTRE) shares declined by 13.43% to $9.35. The market value of their outstanding shares is at $997.9 million. As per the news, the Q4 earnings report came out yesterday.</li>
<li><strong>Amphastar Pharma</strong> (NASDAQ: AMPH) shares fell 13.18% to $23.0. The company's market cap stands at $1.2 billion. The company's, Q4 earnings came out yesterday.</li>
<li><strong>Seer</strong> (NASDAQ: SEER) stock declined by 12.99% to $1.81. The company's market cap stands at $117.0 million. As per the press release, Q4 earnings came out yesterday.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Emergent BioSolutions</strong> (NYSE: EBS) 的股票在週五的盤前交易中下跌了 21.8%，至$8.68。公司的市值為 5.829 億美元。根據新聞，第四季度的財報昨天發佈。</li>
<li><strong>XORTX Therapeutics</strong> (NASDAQ: XRTX) 的股票下跌了 17.58%，至$0.33。其流通股的市值為 280 萬美元。</li>
<li><strong>Ginkgo Bioworks Holdings</strong> (NYSE: DNA) 的股票下跌了 16.69%，至$8.09。其流通股的市值為 5.883 億美元。根據新聞稿，第四季度的財報昨天發佈。</li>
<li><strong>Fortrea Holdings</strong> (NASDAQ: FTRE) 的股票下跌了 13.43%，至$9.35。其流通股的市值為 9.979 億美元。根據新聞，第四季度的財報昨天發佈。</li>
<li><strong>Amphastar Pharma</strong> (NASDAQ: AMPH) 的股票下跌了 13.18%，至$23.0。公司的市值為 12 億美元。公司的第四季度財報昨天發佈。</li>
<li><strong>Seer</strong> (NASDAQ: SEER) 的股票下跌了 12.99%，至$1.81。公司的市值為 1.17 億美元。根據新聞稿，第四季度的財報昨天發佈。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>
</div>

12 只醫療保健股票在週五盤前交易時段的變動